📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Loading analysis...
Manali Petrochemicals Subsidiary PennWhite India Inaugurates New Manufacturing Facility in Chennai
Manali Petrochemicals' step-down subsidiary, PennWhite India, has successfully inaugurated its new manufacturing facility in Oragadam, Chennai. The plant was commissioned within 18 months of the land lease agreement and is designed to manufacture foam control chemistry for the Indian and Asian markets. This facility localizes the production of PennWhite UK's specialty chemical range, which MPL acquired in November 2022. The plant has already secured ISO 9001 certification and aims to replicate UK manufacturing standards locally.
Key Highlights
New manufacturing facility inaugurated at Oragadam, Chennai, for foam control chemistry.
Plant commissioned within 18 months of the land lease agreement executed in early 2025.
Facility is ISO 9001 certified and serves as a strategic hub for the wider Asian market.
Strategic localization of PennWhite UK's portfolio, which includes over 200 specialty chemical products.
Follows the 2022 acquisition of PennWhite UK and the 2024 incorporation of the Indian subsidiary.
💼 Action for Investors
Investors should monitor the revenue contribution from this new facility as it scales up to serve the Asian market. The move into high-margin specialty chemicals via localized production is a positive long-term growth driver for MPL.
Loading analysis...
Manali Petrochemicals Resumes Plant-1 Operations After Government Propylene Allocation
Manali Petrochemicals has announced the phased resumption of operations at its Plant-1 in Chennai starting April 20, 2026. This follows a suspension of operations since March 12, 2026, caused by a total cessation of propylene supply from CPCL. The restart is enabled by a revised government allocation of a fixed daily quantity of propylene specifically to meet pharmaceutical industry requirements. While Plant-1 is restarting, the status quo remains for Plant-2 as per previous communications.
Key Highlights
Resumption of Plant-1 operations in Chennai effective April 20, 2026, after a 39-day suspension.
Department of Pharmaceuticals has allocated a fixed daily quantity of propylene to be supplied by CPCL.
The allocation is specifically designated to meet the requirements of the Pharma Industry.
Operations will resume in a phased manner as feedstock supplies are received.
Plant-2 remains under previous status quo conditions with no immediate change in operational status.
💼 Action for Investors
Investors should view this as a positive step toward restoring production capacity, though full normalcy depends on the status of Plant-2 and consistent feedstock supply.
Loading analysis...
Manali Petrochemicals Receives Madras HC Order on Long-Standing Labor Wage Disputes
Manali Petrochemicals Limited (MANALIPETC) has announced that the Madras High Court has disposed of writ petitions related to labor disputes dating back to 2004 and 2006. These petitions challenged Industrial Tribunal awards concerning wage revisions and service conditions for workmen. The company received the court order on March 31, 2026, and is currently assessing the financial and legal implications. The final impact on the company's balance sheet or profit and loss statement is yet to be quantified.
Key Highlights
Madras High Court disposed of Writ Petitions 5850, 5851 of 2016 and 2731 of 2023 on March 25, 2026.
The case involves Industrial Tribunal awards I.D. No. 35 of 2006 and I.D. No. 51 of 2004.
Disputes pertain to long-standing wage revision and service conditions of the company's workmen.
Company is currently evaluating the financial and legal implications with counsel to determine the next steps.
💼 Action for Investors
Investors should monitor for further disclosures regarding the specific financial liability arising from this court order. A significant retroactive wage revision could impact short-term profitability and cash flows.
Loading analysis...
Manali Petrochemicals Wins ₹3.83 Crore Customs Duty Dispute; CESTAT Rules in Favor
Manali Petrochemicals Limited has received a favorable final order from CESTAT regarding a customs duty dispute dating back to July 2019. The tribunal set aside a demand of ₹3.83 crore plus interest which was originally levied due to the alleged misclassification of imported Quicklime. The ruling confirmed the company's classification was correct as the product purity (91%-95%) was below the 98% threshold required for the higher duty category. The company is now assessing the financial impact of writing back the provisions previously made for this liability.
Key Highlights
CESTAT set aside a customs duty demand of ₹3.83 crore plus interest.
The dispute involved the classification of Quicklime imports under CTI 2522 1000 versus CTI 2825 9090.
Tribunal ruled in favor of the company as the Calcium Oxide purity was between 91% and 95%.
The company will assess the write-back of provisions made for this demand, which will positively impact the bottom line.
💼 Action for Investors
Investors should view this as a positive development that clears a long-standing legal liability and will likely result in a one-time boost to profits through a provision reversal. Monitor the next quarterly earnings for the specific financial impact of this write-back.
Loading analysis...
Manali Petrochemicals Wins ₹3.83 Crore Customs Duty Dispute; CESTAT Sets Aside Demand
Manali Petrochemicals has received a favorable final order from CESTAT regarding a customs duty dispute dating back to 2019. The tribunal set aside a demand of ₹3.83 crore plus interest related to the alleged misclassification of imported Quicklime. The ruling confirmed that the company's classification was correct as the Calcium Oxide purity (91%-95%) was below the 98% threshold required for the higher duty category. The company is now assessing the financial impact of writing back the provisions previously made for this liability.
Key Highlights
CESTAT set aside a customs duty demand of ₹3.83 crore plus interest in its entirety.
The dispute involved the classification of Quicklime imports under CTI 2522 1000 versus CTI 2825 9090.
Tribunal ruled in favor of the company as the purity of goods (91%-95%) did not meet the 98% threshold for higher duty.
The company will assess and likely write back provisions made for this liability, boosting future net profit.
💼 Action for Investors
This is a positive development that removes a long-standing legal liability and will likely lead to a one-time gain via provision reversal. Investors should look for the specific financial impact in the upcoming quarterly earnings report.
Loading analysis...
Manali Petrochemicals: Madras High Court Disposes Writ Petitions on Wage Revision Case
Manali Petrochemicals has received a common order from the Madras High Court regarding long-standing industrial disputes from 2004 and 2006. The court has disposed of the company's writ petitions which challenged previous tribunal awards concerning wage revisions and service conditions for workmen. The company is currently assessing the financial and legal implications of this order with its legal counsel. Investors should be aware that this could lead to potential back-pay liabilities or increased operational costs once the impact is quantified.
Key Highlights
Madras High Court disposed of Writ Petitions W.P. Nos. 5850, 5851 of 2016 and 2731 of 2023 on March 25, 2026.
The legal dispute pertains to Industrial Tribunal awards in I.D. Nos. 35 of 2006 and 51 of 2004.
The core issue involves wage revision and service conditions for the company's workmen dating back over two decades.
Company is currently evaluating the financial impact and will take appropriate steps as advised by counsel.
💼 Action for Investors
Investors should monitor for subsequent disclosures regarding the specific financial liability or provisions the company may need to make. The scale of the impact will depend on the extent of wage arrears and revised service terms mandated by the court order.
Loading analysis...
Manali Petrochemicals Wins 30-Year Legal Battle; Rs 10.82 Cr Claim Dismissed
Manali Petrochemicals Limited has received a favorable judgment in a long-standing civil suit filed by Unimark Remedies Ltd. in 1995. The suit sought damages and specific performance regarding a 1995 MOU, with a claim value of Rs 10.82 crore plus interest. The Hon’ble City Civil Court, Mumbai, dismissed the suit in favor of the company on February 11, 2026. This resolution effectively removes a decades-old contingent liability from the company's financial outlook.
Key Highlights
Mumbai City Civil Court dismissed the 1995 civil suit filed by Unimark Remedies Ltd.
The legal dispute involved a claim of Rs 10.82 crore plus additional interest.
The case originated from a Memorandum of Understanding (MOU) dated May 17, 1995.
The ruling eliminates a potential financial liability that has been pending for over 30 years.
The company was formerly known as U.B. Petroproducts Ltd. during the time of the initial filing.
💼 Action for Investors
Investors should view this as a positive development that clears a long-term legal overhang and protects the company's cash flows from a potential payout. No immediate action is required, but it improves the overall risk profile of the stock.
Loading analysis...
Manali Petrochemicals Q3 Consolidated PAT Jumps to Rs 68.43 Cr Aided by Subsidiary Sale
Manali Petrochemicals reported a consolidated PAT of Rs 68.43 crore for the quarter ended December 2025, a sharp rise from Rs 18.15 crore in the preceding quarter. The total consolidated income stood at Rs 266.80 crore, showing steady growth from Rs 260.94 crore. A key driver for the profit surge was the gain on disposal of a UK subsidiary, alongside consistent performance from other international units. Standalone PBT also improved to Rs 5.09 crore, reflecting better operational efficiencies compared to the previous quarter's Rs 0.19 crore.
Key Highlights
Consolidated PAT increased to Rs 68.43 crore in Q3 FY26 from Rs 18.15 crore in Q2 FY26.
Total consolidated income grew to Rs 266.80 crore compared to Rs 260.94 crore in the previous quarter.
Standalone PBT improved significantly to Rs 5.09 crore from Rs 0.19 crore on a quarter-on-quarter basis.
Profitability was significantly boosted by a one-time gain from the disposal of a UK subsidiary.
Management remains focused on cost optimization and product mix to counter macro-economic uncertainty.
💼 Action for Investors
Investors should note that the substantial profit surge is largely due to a non-recurring gain from a subsidiary sale. Focus on the recovery in standalone margins and core petrochemical demand in upcoming quarters to assess long-term value.
Loading analysis...
Manali Petrochemicals Q3 Net Profit Rises to ₹4.55 Cr; Revenue Up 38% YoY
Manali Petrochemicals reported a significant turnaround in Q3 FY26, posting a net profit of ₹4.55 crore compared to a loss of ₹2.83 crore in the same quarter last year. Revenue from operations grew 38% year-on-year to ₹195.14 crore, reflecting improved operational performance. The company navigated several exceptional items, including a ₹45.87 lakh gain from land sale and a ₹33.62 lakh provision for new labour codes. While inventory insurance claims from Cyclone Michaung are settled, a substantial ₹12.26 crore claim for property damage remains under assessment by insurers.
Key Highlights
Revenue from operations increased 38% YoY to ₹195.14 crore in Q3 FY26.
Net profit stood at ₹4.55 crore, recovering from a net loss of ₹2.83 crore in the year-ago period.
Profit Before Tax (PBT) reached ₹5.09 crore, despite a net exceptional loss of ₹1.41 crore during the quarter.
Insurance claims of ₹12.26 crore for property, plant, and equipment damage are still pending final assessment.
Lease renewal for the Unit-II manufacturing site remains pending with the Government of Tamil Nadu since 2017.
💼 Action for Investors
The company has demonstrated a strong recovery in profitability and revenue growth, suggesting a cyclical upturn. Investors should monitor the final settlement of the ₹12.26 crore insurance claim and the status of the Unit-II lease renewal for long-term operational stability.